ORDA - Online Research Data Archive 
    • Login
    View Item 
    •   ORDA Home
    • Sherwood Forest Hospitals NHS Foundation Trust
    • Medicine Division
    • Haematology
    • View Item
    •   ORDA Home
    • Sherwood Forest Hospitals NHS Foundation Trust
    • Medicine Division
    • Haematology
    • View Item
    JavaScript is disabled for your browser. Some features of this site may not work without it.

    Modification of escalated beacopp with dacarbazine / procarbazine substitution reduces red cell transfusion requirements and may shorten time to menstrual period recovery

    Thumbnail
    Abstract
    It is increasingly common practice to modify escalated BEACOPP (eBPP) by removing oral procarbazine and replacing with intravenous dacarbazine (250mg/m2 D2‐3), hoping to reduce haematopoietic stem cell and gonadal toxicity. However, published data on the so‐called ‘escalated BEACOPDac (eBPDac)’ regimen are limited.
    URI
    https://orda.derbyhospitals.nhs.uk/handle/123456789/2188
    Collections
    • Haematology [3]
    Date
    2019-06
    Author
    Jones, Steve
    Show full item record

    copyright © 2017  Derby Teaching Hospitals NHS Foundation Trust
    Contact Us | Send Feedback
    Powered by KnowledgeArc
     

     

    Browse

    All of ORDACommunities & CollectionsBy Issue DateAuthorsTitlesSubjectsThis CollectionBy Issue DateAuthorsTitlesSubjects

    Researcher Profiles

    Researchers

    My Account

    Login

    copyright © 2017  Derby Teaching Hospitals NHS Foundation Trust
    Contact Us | Send Feedback
    Powered by KnowledgeArc